Maravai Lifesciences Holdings (MRVI) Other Operating Expenses (2020 - 2025)

Maravai Lifesciences Holdings' Other Operating Expenses history runs 6 years deep, the most recent figure standing at $25.8 million for Q4 2025.

• In Q4 2025, Other Operating Expenses rose 128.9% year-over-year to $25.8 million; the TTM figure through Mar 2026 stood at $96.1 million (down 55.34% YoY), while the FY2025 annual figure was $68.9 million, down 58.02% from the prior year.
• Other Operating Expenses for Q4 2025 stood at $25.8 million, up from $60000.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $154.1 million in Q3 2024, with the low at -$117.0 million in Q4 2023.
• The 5-year median for Other Operating Expenses is $33.7 million (2023), against an average of $29.2 million.
• The sharpest annual moves came in 2021 and 2025: Other Operating Expenses jumped 947.26% in 2021, then slumped 99.96% in 2025.
• Maravai Lifesciences Holdings' Other Operating Expenses stood at $11.2 million in 2021, then surged by 163.99% to $29.7 million in 2022, then slumped by 493.96% to -$117.0 million in 2023, then jumped by 109.64% to $11.3 million in 2024, then soared by 128.9% to $25.8 million in 2025.
• Business Quant data shows MRVI's Other Operating Expenses at $25.8 million in Q4 2025, $60000.0 in Q3 2025, and $70.2 million in Q2 2025.